Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Association of a HOXB13 variant with breast cancer.

Alanee S, Couch F, Offit K.

N Engl J Med. 2012 Aug 2;367(5):480-1. doi: 10.1056/NEJMc1205138. No abstract available.

PMID:
22853031
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.

Akbari MR, Kluźniak W, Rodin R, Li S, Wokołorczyk D, Royer R, Kashyap A, Menkiszak J, Lubinski J, Narod SA, Cybulski C.

Breast Cancer Res Treat. 2012 Dec;136(3):907-9. doi: 10.1007/s10549-012-2295-y. Epub 2012 Oct 26.

PMID:
23099437
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.

Goetz MP, Suman VJ, Couch FJ, Ames MM, Rae JM, Erlander MG, Ma XJ, Sgroi DC, Reynolds CA, Lingle WL, Weinshilboum RM, Flockhart DA, Desta Z, Perez EA, Ingle JN.

Clin Cancer Res. 2008 Sep 15;14(18):5864-8. doi: 10.1158/1078-0432.CCR-08-0619.

PMID:
18794098
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.

Akbari MR, Anderson LN, Buchanan DD, Clendenning M, Jenkins MA, Win AK, Hopper JL, Giles GG, Nam R, Narod S, Gallinger S, Cleary SP.

Cancer Epidemiol. 2013 Aug;37(4):424-7. doi: 10.1016/j.canep.2013.03.003. Epub 2013 Mar 26.

PMID:
23541221
[PubMed - indexed for MEDLINE]
5.

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.

Laitinen VH, Wahlfors T, Saaristo L, Rantapero T, Pelttari LM, Kilpivaara O, Laasanen SL, Kallioniemi A, Nevanlinna H, Aaltonen L, Vessella RL, Auvinen A, Visakorpi T, Tammela TL, Schleutker J.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):452-60. doi: 10.1158/1055-9965.EPI-12-1000-T. Epub 2013 Jan 4.

PMID:
23292082
[PubMed - indexed for MEDLINE]
Free Article
6.

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.

Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7.

PMID:
16609019
[PubMed - indexed for MEDLINE]
Free Article
7.

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.

Jansen MP, Sieuwerts AM, Look MP, Ritstier K, Meijer-van Gelder ME, van Staveren IL, Klijn JG, Foekens JA, Berns EM.

J Clin Oncol. 2007 Feb 20;25(6):662-8.

PMID:
17308270
[PubMed - indexed for MEDLINE]
8.

Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.

Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1348-53. doi: 10.1158/1055-9965.EPI-12-0495. Epub 2012 Jun 19.

PMID:
22714738
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.

Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, Bender RA, Osborne CK, Allred DC, Erlander MG.

J Clin Oncol. 2006 Oct 1;24(28):4611-9.

PMID:
17008703
[PubMed - indexed for MEDLINE]
10.

Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.

Jerevall PL, Brommesson S, Strand C, Gruvberger-Saal S, Malmström P, Nordenskjöld B, Wingren S, Söderkvist P, Fernö M, Stål O.

Breast Cancer Res Treat. 2008 Jan;107(2):225-34. Epub 2007 Apr 24.

PMID:
17453342
[PubMed - indexed for MEDLINE]
11.

Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.

Rodriguez BA, Cheng AS, Yan PS, Potter D, Agosto-Perez FJ, Shapiro CL, Huang TH.

Carcinogenesis. 2008 Jul;29(7):1459-65. doi: 10.1093/carcin/bgn115. Epub 2008 May 21.

PMID:
18499701
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.

Jerevall PL, Jansson A, Fornander T, Skoog L, Nordenskjöld B, Stål O.

Breast Cancer Res. 2010;12(4):R53. doi: 10.1186/bcr2612. Epub 2010 Jul 22.

PMID:
20649975
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG, Sgroi DC.

Cancer Cell. 2004 Jun;5(6):607-16.

PMID:
15193263
[PubMed - indexed for MEDLINE]
Free Article
14.

A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.

Lin X, Qu L, Chen Z, Xu C, Ye D, Shao Q, Wang X, Qi J, Chen Z, Zhou F, Wang M, Wang Z, He D, Wu D, Gao X, Yuan J, Wang G, Xu Y, Wang G, Dong P, Jiao Y, Yang J, Ou-Yang J, Jiang H, Zhu Y, Ren S, Zhang Z, Yin C, Wu Q, Zheng Y, Turner AR, Tao S, Na R, Ding Q, Lu D, Shi R, Sun J, Liu F, Zheng SL, Mo Z, Sun Y, Xu J.

Prostate. 2013 Jan;73(2):169-75. doi: 10.1002/pros.22552. Epub 2012 Jun 21.

PMID:
22718278
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Association between germline HOXB13 G84E mutation and risk of prostate cancer.

Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, Narod SA, Nam RK.

J Natl Cancer Inst. 2012 Aug 22;104(16):1260-2. doi: 10.1093/jnci/djs288. Epub 2012 Jul 9.

PMID:
22781434
[PubMed - indexed for MEDLINE]
Free Article
16.

Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.

Lewis AG, Flanagan J, Marsh A, Pupo GM, Mann G, Spurdle AB, Lindeman GJ, Visvader JE, Brown MA, Chenevix-Trench G; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

Breast Cancer Res. 2005;7(6):R1005-16. Epub 2005 Oct 21.

PMID:
16280053
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Limits of predictive models using microarray data for breast cancer clinical treatment outcome.

Reid JF, Lusa L, De Cecco L, Coradini D, Veneroni S, Daidone MG, Gariboldi M, Pierotti MA.

J Natl Cancer Inst. 2005 Jun 15;97(12):927-30.

PMID:
15956654
[PubMed - indexed for MEDLINE]
Free Article
18.

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer.

Ma XJ, Salunga R, Dahiya S, Wang W, Carney E, Durbecq V, Harris A, Goss P, Sotiriou C, Erlander M, Sgroi D.

Clin Cancer Res. 2008 May 1;14(9):2601-8. doi: 10.1158/1078-0432.CCR-07-5026.

PMID:
18451222
[PubMed - indexed for MEDLINE]
Free Article
19.

Infrequent mutation of ATBF1 in human breast cancer.

Sun X, Zhou Y, Otto KB, Wang M, Chen C, Zhou W, Subramanian K, Vertino PM, Dong JT.

J Cancer Res Clin Oncol. 2007 Feb;133(2):103-5. Epub 2006 Aug 24.

PMID:
16932943
[PubMed - indexed for MEDLINE]
20.

Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification.

Chong LY, Cheok PY, Tan WJ, Thike AA, Allen G, Ang MK, Ooi AS, Tan P, Teh BT, Tan PH.

Breast Cancer Res Treat. 2012 Feb;132(1):143-51. doi: 10.1007/s10549-011-1555-6. Epub 2011 May 15.

PMID:
21574054
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk